Focus Partners Advisor Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Focus Partners Advisor Solutions’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,903	Closed	-$321K	–	1326
2026 Q1	$321K	Sell	1,903 -304	-14%	-$52K	﹤0.01%	944
2025 Q4	$373K	Sell	2,207 -1,385	-39%	-$225K	﹤0.01%	813
2025 Q3	$567K	Buy	3,592 +1,421	+65%	+$194K	0.01%	694
2025 Q2	$275K	Buy	2,171 +162	+8%	+$19.9K	﹤0.01%	902
2025 Q1	$257K	Buy	+2,009	New	+$272K	﹤0.01%	820
2024 Q4	–	Sell	-2,153	Closed	-$314K	–	816
2024 Q3	$314K	Sell	2,153 -66	-3%	-$9.55K	0.01%	561
2024 Q2	$305K	Buy	+2,219	New	+$296K	0.01%	483

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Focus Partners Advisor Solutions's IBB Position: Q2 2026 in Review

Focus Partners Advisor Solutions sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 1,903 shares — an estimated $321K sold.

Focus Partners Advisor Solutions first reported a position in IBB in Q2 2024 and held it in 7 quarters. The position peaked at $567K in Q3 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Focus Partners Advisor Solutions reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
Focus Partners Advisor Solutions sold 1,903 iShares Biotechnology ETF shares in Q2 2026, an estimated $321K.
Focus Partners Advisor Solutions first reported a position in iShares Biotechnology ETF in Q2 2024 and held it in 7 quarters.
Focus Partners Advisor Solutions's iShares Biotechnology ETF position peaked at $567K in Q3 2025.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.